NCT01894555View on ClinicalTrials.gov

Pharmacogenomics of Antiplatelet Response - II (PARes-II)

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Atherothrombosis
Interventions
DRUG

Aspirin

81 mg daily for 4 weeks

Trial Locations (1)

21287

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT01894555 - Pharmacogenomics of Antiplatelet Response - II (PARes-II) | Biotech Hunter | Biotech Hunter